APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Anti-Infective Products

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global OTC Anti-Infective Products Market Analysis and Forecast 2026-2032

29 December 2025195 pages

Choose your research edition.

Industry ResearchOTC Anti-Infective Products Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Anti-Infective Products Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal OTC Anti-Infective Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Anti-Infective Products Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Anti-Infective Products Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global OTC Anti-Infective Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for OTC Anti-Infective Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for OTC Anti-Infective Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for OTC Anti-Infective Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for OTC Anti-Infective Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of OTC Anti-Infective Products include Teva, Johnson & Johnson, NOVARTIS, MYLAN, Roche, Lingrui, Pfizer, CR SANJIU and GSK, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for OTC Anti-Infective Products, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of OTC Anti-Infective Products, also provides the sales of main regions and countries. Of the upcoming market potential for OTC Anti-Infective Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the OTC Anti-Infective Products sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global OTC Anti-Infective Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for OTC Anti-Infective Products sales, projected growth trends, production technology, application and end-user industry.

OTC Anti-Infective Products Segment by Company

Teva

Johnson & Johnson

NOVARTIS

MYLAN

Roche

Lingrui

Pfizer

CR SANJIU

GSK

Bayer

Sun Pharma

Gilead Sciences

Cipla

Bausch Health

Astellas Pharma

OTC Anti-Infective Products Segment by Type

Antiviral

Antibacterial

Antifungal

Antiseptics

Others

OTC Anti-Infective Products Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

OTC Anti-Infective Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Anti-Infective Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Anti-Infective Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Anti-Infective Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of OTC Anti-Infective Products in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of OTC Anti-Infective Products manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Anti-Infective Products sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global OTC Anti-Infective Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Antiviral Major Manufacturers Table 3. Antibacterial Major Manufacturers Table 4. Antifungal Major Manufacturers Table 5. Antiseptics Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global OTC Anti-Infective Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Retail Pharmacies Major Manufacturers Table 9. Online Pharmacies Major Manufacturers Table 10. Hospital Pharmacies Major Manufacturers Table 11. OTC Anti-Infective Products Industry Trends Table 12. OTC Anti-Infective Products Industry Drivers Table 13. OTC Anti-Infective Products Industry Opportunities and Challenges Table 14. OTC Anti-Infective Products Industry Restraints Table 15. Global OTC Anti-Infective Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global OTC Anti-Infective Products Revenue by Region (2021-2026) & (US$ Million) Table 17. Global OTC Anti-Infective Products Revenue by Region (2027-2032) & (US$ Million) Table 18. Global OTC Anti-Infective Products Revenue Market Share by Region (2021-2026) Table 19. Global OTC Anti-Infective Products Revenue Market Share by Region (2027-2032) Table 20. Global OTC Anti-Infective Products Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 21. Global OTC Anti-Infective Products Sales by Region (2021-2026) & (M Units) Table 22. Global OTC Anti-Infective Products Sales by Region (2027-2032) & (M Units) Table 23. Global OTC Anti-Infective Products Sales Market Share by Region (2021-2026) Table 24. Global OTC Anti-Infective Products Sales Market Share by Region (2027-2032) Table 25. Global OTC Anti-Infective Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global OTC Anti-Infective Products Revenue Market Share by Manufacturers (2021-2026) Table 27. Global OTC Anti-Infective Products Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2021-2026) Table 29. Global OTC Anti-Infective Products Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global OTC Anti-Infective Products Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global OTC Anti-Infective Products Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global OTC Anti-Infective Products Manufacturers, Product Type & Application Table 33. Global OTC Anti-Infective Products Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global OTC Anti-Infective Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global OTC Anti-Infective Products Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global OTC Anti-Infective Products Revenue by Type (2021-2026) & (US$ Million) Table 38. Global OTC Anti-Infective Products Revenue by Type (2027-2032) & (US$ Million) Table 39. Global OTC Anti-Infective Products Revenue Market Share by Type (2021-2026) Table 40. Global OTC Anti-Infective Products Revenue Market Share by Type (2027-2032) Table 41. Global OTC Anti-Infective Products Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 42. Global OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 43. Global OTC Anti-Infective Products Sales by Type (2027-2032) & (M Units) Table 44. Global OTC Anti-Infective Products Sales Market Share by Type (2021-2026) Table 45. Global OTC Anti-Infective Products Sales Market Share by Type (2027-2032) Table 46. Global OTC Anti-Infective Products Price by Type (2021-2026) & (US$/Unit) Table 47. Global OTC Anti-Infective Products Price by Type (2027-2032) & (US$/Unit) Table 48. Global OTC Anti-Infective Products Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global OTC Anti-Infective Products Revenue by Application (2021-2026) & (US$ Million) Table 50. Global OTC Anti-Infective Products Revenue by Application (2027-2032) & (US$ Million) Table 51. Global OTC Anti-Infective Products Revenue Market Share by Application (2021-2026) Table 52. Global OTC Anti-Infective Products Revenue Market Share by Application (2027-2032) Table 53. Global OTC Anti-Infective Products Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 54. Global OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 55. Global OTC Anti-Infective Products Sales by Application (2027-2032) & (M Units) Table 56. Global OTC Anti-Infective Products Sales Market Share by Application (2021-2026) Table 57. Global OTC Anti-Infective Products Sales Market Share by Application (2027-2032) Table 58. Global OTC Anti-Infective Products Price by Application (2021-2026) & (US$/Unit) Table 59. Global OTC Anti-Infective Products Price by Application (2027-2032) & (US$/Unit) Table 60. Teva Company Information Table 61. Teva Business Overview Table 62. Teva OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Teva OTC Anti-Infective Products Product Portfolio Table 64. Teva Recent Development Table 65. Johnson & Johnson Company Information Table 66. Johnson & Johnson Business Overview Table 67. Johnson & Johnson OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Johnson & Johnson OTC Anti-Infective Products Product Portfolio Table 69. Johnson & Johnson Recent Development Table 70. NOVARTIS Company Information Table 71. NOVARTIS Business Overview Table 72. NOVARTIS OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. NOVARTIS OTC Anti-Infective Products Product Portfolio Table 74. NOVARTIS Recent Development Table 75. MYLAN Company Information Table 76. MYLAN Business Overview Table 77. MYLAN OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. MYLAN OTC Anti-Infective Products Product Portfolio Table 79. MYLAN Recent Development Table 80. Roche Company Information Table 81. Roche Business Overview Table 82. Roche OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Roche OTC Anti-Infective Products Product Portfolio Table 84. Roche Recent Development Table 85. Lingrui Company Information Table 86. Lingrui Business Overview Table 87. Lingrui OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Lingrui OTC Anti-Infective Products Product Portfolio Table 89. Lingrui Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Pfizer OTC Anti-Infective Products Product Portfolio Table 94. Pfizer Recent Development Table 95. CR SANJIU Company Information Table 96. CR SANJIU Business Overview Table 97. CR SANJIU OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. CR SANJIU OTC Anti-Infective Products Product Portfolio Table 99. CR SANJIU Recent Development Table 100. GSK Company Information Table 101. GSK Business Overview Table 102. GSK OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. GSK OTC Anti-Infective Products Product Portfolio Table 104. GSK Recent Development Table 105. Bayer Company Information Table 106. Bayer Business Overview Table 107. Bayer OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Bayer OTC Anti-Infective Products Product Portfolio Table 109. Bayer Recent Development Table 110. Sun Pharma Company Information Table 111. Sun Pharma Business Overview Table 112. Sun Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Sun Pharma OTC Anti-Infective Products Product Portfolio Table 114. Sun Pharma Recent Development Table 115. Gilead Sciences Company Information Table 116. Gilead Sciences Business Overview Table 117. Gilead Sciences OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Gilead Sciences OTC Anti-Infective Products Product Portfolio Table 119. Gilead Sciences Recent Development Table 120. Cipla Company Information Table 121. Cipla Business Overview Table 122. Cipla OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Cipla OTC Anti-Infective Products Product Portfolio Table 124. Cipla Recent Development Table 125. Bausch Health Company Information Table 126. Bausch Health Business Overview Table 127. Bausch Health OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Bausch Health OTC Anti-Infective Products Product Portfolio Table 129. Bausch Health Recent Development Table 130. Astellas Pharma Company Information Table 131. Astellas Pharma Business Overview Table 132. Astellas Pharma OTC Anti-Infective Products Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Astellas Pharma OTC Anti-Infective Products Product Portfolio Table 134. Astellas Pharma Recent Development Table 135. North America OTC Anti-Infective Products Revenue by Type (2021-2026) & (US$ Million) Table 136. North America OTC Anti-Infective Products Revenue by Type (2027-2032) & (US$ Million) Table 137. North America OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 138. North America OTC Anti-Infective Products Sales by Type (2027-2032) & (M Units) Table 139. North America OTC Anti-Infective Products Sales Price by Type (2021-2026) & (US$/Unit) Table 140. North America OTC Anti-Infective Products Sales Price by Type (2027-2032) & (US$/Unit) Table 141. North America OTC Anti-Infective Products Revenue by Application (2021-2026) & (US$ Million) Table 142. North America OTC Anti-Infective Products Revenue by Application (2027-2032) & (US$ Million) Table 143. North America OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 144. North America OTC Anti-Infective Products Sales by Application (2027-2032) & (M Units) Table 145. North America OTC Anti-Infective Products Sales Price by Application (2021-2026) & (US$/Unit) Table 146. North America OTC Anti-Infective Products Sales Price by Application (2027-2032) & (US$/Unit) Table 147. North America OTC Anti-Infective Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America OTC Anti-Infective Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. North America OTC Anti-Infective Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. North America OTC Anti-Infective Products Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 151. North America OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 152. North America OTC Anti-Infective Products Sales by Country (2027-2032) & (M Units) Table 153. North America OTC Anti-Infective Products Sales Price by Country (2021-2026) & (US$/Unit) Table 154. North America OTC Anti-Infective Products Sales Price by Country (2027-2032) & (US$/Unit) Table 155. United States OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 156. Canada OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 157. Europe OTC Anti-Infective Products Revenue by Type (2021-2026) & (US$ Million) Table 158. Europe OTC Anti-Infective Products Revenue by Type (2027-2032) & (US$ Million) Table 159. Europe OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 160. Europe OTC Anti-Infective Products Sales by Type (2027-2032) & (M Units) Table 161. Europe OTC Anti-Infective Products Sales Price by Type (2021-2026) & (US$/Unit) Table 162. Europe OTC Anti-Infective Products Sales Price by Type (2027-2032) & (US$/Unit) Table 163. Europe OTC Anti-Infective Products Revenue by Application (2021-2026) & (US$ Million) Table 164. Europe OTC Anti-Infective Products Revenue by Application (2027-2032) & (US$ Million) Table 165. Europe OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 166. Europe OTC Anti-Infective Products Sales by Application (2027-2032) & (M Units) Table 167. Europe OTC Anti-Infective Products Sales Price by Application (2021-2026) & (US$/Unit) Table 168. Europe OTC Anti-Infective Products Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Europe OTC Anti-Infective Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Europe OTC Anti-Infective Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Europe OTC Anti-Infective Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Europe OTC Anti-Infective Products Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 173. Europe OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 174. Europe OTC Anti-Infective Products Sales by Country (2027-2032) & (M Units) Table 175. Europe OTC Anti-Infective Products Sales Price by Country (2021-2026) & (US$/Unit) Table 176. Europe OTC Anti-Infective Products Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Germany OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 178. France OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 179. U.K. OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 180. Italy OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 181. Netherlands OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 182. Nordic Countries OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 183. China OTC Anti-Infective Products Revenue by Type (2021-2026) & (US$ Million) Table 184. China OTC Anti-Infective Products Revenue by Type (2027-2032) & (US$ Million) Table 185. China OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 186. China OTC Anti-Infective Products Sales by Type (2027-2032) & (M Units) Table 187. China OTC Anti-Infective Products Sales Price by Type (2021-2026) & (US$/Unit) Table 188. China OTC Anti-Infective Products Sales Price by Type (2027-2032) & (US$/Unit) Table 189. China OTC Anti-Infective Products Revenue by Application (2021-2026) & (US$ Million) Table 190. China OTC Anti-Infective Products Revenue by Application (2027-2032) & (US$ Million) Table 191. China OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 192. China OTC Anti-Infective Products Sales by Application (2027-2032) & (M Units) Table 193. China OTC Anti-Infective Products Sales Price by Application (2021-2026) & (US$/Unit) Table 194. China OTC Anti-Infective Products Sales Price by Application (2027-2032) & (US$/Unit) Table 195. Asia OTC Anti-Infective Products Revenue by Type (2021-2026) & (US$ Million) Table 196. Asia OTC Anti-Infective Products Revenue by Type (2027-2032) & (US$ Million) Table 197. Asia OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 198. Asia OTC Anti-Infective Products Sales by Type (2027-2032) & (M Units) Table 199. Asia OTC Anti-Infective Products Sales Price by Type (2021-2026) & (US$/Unit) Table 200. Asia OTC Anti-Infective Products Sales Price by Type (2027-2032) & (US$/Unit) Table 201. Asia OTC Anti-Infective Products Revenue by Application (2021-2026) & (US$ Million) Table 202. Asia OTC Anti-Infective Products Revenue by Application (2027-2032) & (US$ Million) Table 203. Asia OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 204. Asia OTC Anti-Infective Products Sales by Application (2027-2032) & (M Units) Table 205. Asia OTC Anti-Infective Products Sales Price by Application (2021-2026) & (US$/Unit) Table 206. Asia OTC Anti-Infective Products Sales Price by Application (2027-2032) & (US$/Unit) Table 207. Asia OTC Anti-Infective Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 208. Asia OTC Anti-Infective Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 209. Asia OTC Anti-Infective Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 210. Asia OTC Anti-Infective Products Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 211. Asia OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 212. Asia OTC Anti-Infective Products Sales by Country (2027-2032) & (M Units) Table 213. Asia OTC Anti-Infective Products Sales Price by Country (2021-2026) & (US$/Unit) Table 214. Asia OTC Anti-Infective Products Sales Price by Country (2027-2032) & (US$/Unit) Table 215. Japan OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 216. South Korea OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 217. India OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 218. Australia OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 219. China Taiwan OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 220. Southeast Asia OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 221. SAMEA OTC Anti-Infective Products Revenue by Type (2021-2026) & (US$ Million) Table 222. SAMEA OTC Anti-Infective Products Revenue by Type (2027-2032) & (US$ Million) Table 223. SAMEA OTC Anti-Infective Products Sales by Type (2021-2026) & (M Units) Table 224. SAMEA OTC Anti-Infective Products Sales by Type (2027-2032) & (M Units) Table 225. SAMEA OTC Anti-Infective Products Sales Price by Type (2021-2026) & (US$/Unit) Table 226. SAMEA OTC Anti-Infective Products Sales Price by Type (2027-2032) & (US$/Unit) Table 227. SAMEA OTC Anti-Infective Products Revenue by Application (2021-2026) & (US$ Million) Table 228. SAMEA OTC Anti-Infective Products Revenue by Application (2027-2032) & (US$ Million) Table 229. SAMEA OTC Anti-Infective Products Sales by Application (2021-2026) & (M Units) Table 230. SAMEA OTC Anti-Infective Products Sales by Application (2027-2032) & (M Units) Table 231. SAMEA OTC Anti-Infective Products Sales Price by Application (2021-2026) & (US$/Unit) Table 232. SAMEA OTC Anti-Infective Products Sales Price by Application (2027-2032) & (US$/Unit) Table 233. SAMEA OTC Anti-Infective Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 234. SAMEA OTC Anti-Infective Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 235. SAMEA OTC Anti-Infective Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 236. SAMEA OTC Anti-Infective Products Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 237. SAMEA OTC Anti-Infective Products Sales by Country (2021-2026) & (M Units) Table 238. SAMEA OTC Anti-Infective Products Sales by Country (2027-2032) & (M Units) Table 239. SAMEA OTC Anti-Infective Products Sales Price by Country (2021-2026) & (US$/Unit) Table 240. SAMEA OTC Anti-Infective Products Sales Price by Country (2027-2032) & (US$/Unit) Table 241. Brazil OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 242. Argentina OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 243. Chile OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 244. Colombia OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 245. Peru OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 246. Saudi Arabia OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 247. Israel OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 248. UAE OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 249. Turkey OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 250. Iran OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 251. Egypt OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Table 252. Key Raw Materials Table 253. Raw Materials Key Suppliers Table 254. OTC Anti-Infective Products Distributors List Table 255. OTC Anti-Infective Products Customers List Table 256. Research Programs/Design for This Report Table 257. Authors List of This Report Table 258. Secondary Sources Table 259. Primary Sources List of Figures Figure 1. OTC Anti-Infective Products Image Figure 2. Global OTC Anti-Infective Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Anti-Infective Products Market Size Share 2021 VS 2025 VS 2032 Figure 4. Antiviral Image Figure 5. Antibacterial Image Figure 6. Antifungal Image Figure 7. Antiseptics Image Figure 8. Others Image Figure 9. Global OTC Anti-Infective Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global OTC Anti-Infective Products Market Size Share 2021 VS 2025 VS 2032 Figure 11. Retail Pharmacies Image Figure 12. Online Pharmacies Image Figure 13. Hospital Pharmacies Image Figure 14. Global OTC Anti-Infective Products Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global OTC Anti-Infective Products Revenue (2021-2032) & (US$ Million) Figure 16. Global OTC Anti-Infective Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global OTC Anti-Infective Products Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global OTC Anti-Infective Products Revenue Market Share by Region (2021-2032) Figure 19. Global OTC Anti-Infective Products Sales (2021-2032) & (M Units) Figure 20. Global OTC Anti-Infective Products Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 21. Global OTC Anti-Infective Products Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico OTC Anti-Infective Products Sales YoY (2021-2032) & (M Units) Figure 23. Europe OTC Anti-Infective Products Sales YoY (2021-2032) & (M Units) Figure 24. China OTC Anti-Infective Products Sales YoY (2021-2032) & (M Units) Figure 25. Asia (Excluding China) OTC Anti-Infective Products Sales YoY (2021-2032) & (M Units) Figure 26. South America, Middle East and Africa OTC Anti-Infective Products Sales YoY (2021-2032) & (M Units) Figure 27. Global OTC Anti-Infective Products Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global OTC Anti-Infective Products Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global OTC Anti-Infective Products Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global OTC Anti-Infective Products Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global OTC Anti-Infective Products Revenue Market Share by Type (2021-2032) Figure 33. Global OTC Anti-Infective Products Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 34. Global OTC Anti-Infective Products Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global OTC Anti-Infective Products Sales Market Share by Type (2021-2032) Figure 36. Global OTC Anti-Infective Products Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global OTC Anti-Infective Products Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global OTC Anti-Infective Products Revenue Market Share by Application (2021-2032) Figure 39. Global OTC Anti-Infective Products Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 40. Global OTC Anti-Infective Products Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global OTC Anti-Infective Products Sales Market Share by Application (2021-2032) Figure 42. North America OTC Anti-Infective Products Revenue Share by Type (2021-2032) Figure 43. North America OTC Anti-Infective Products Sales Share by Type (2021-2032) Figure 44. North America OTC Anti-Infective Products Revenue Share by Application (2021-2032) Figure 45. North America OTC Anti-Infective Products Sales Share by Application (2021-2032) Figure 46. North America OTC Anti-Infective Products Revenue Share by Country (2021-2032) Figure 47. North America OTC Anti-Infective Products Sales Share by Country (2021-2032) Figure 48. Europe OTC Anti-Infective Products Revenue Share by Type (2021-2032) Figure 49. Europe OTC Anti-Infective Products Sales Share by Type (2021-2032) Figure 50. Europe OTC Anti-Infective Products Revenue Share by Application (2021-2032) Figure 51. Europe OTC Anti-Infective Products Sales Share by Application (2021-2032) Figure 52. Europe OTC Anti-Infective Products Revenue Share by Country (2021-2032) Figure 53. Europe OTC Anti-Infective Products Sales Share by Country (2021-2032) Figure 54. China OTC Anti-Infective Products Revenue Share by Type (2021-2032) Figure 55. China OTC Anti-Infective Products Sales Share by Type (2021-2032) Figure 56. China OTC Anti-Infective Products Revenue Share by Application (2021-2032) Figure 57. China OTC Anti-Infective Products Sales Share by Application (2021-2032) Figure 58. Asia OTC Anti-Infective Products Revenue Share by Type (2021-2032) Figure 59. Asia OTC Anti-Infective Products Sales Share by Type (2021-2032) Figure 60. Asia OTC Anti-Infective Products Revenue Share by Application (2021-2032) Figure 61. Asia OTC Anti-Infective Products Sales Share by Application (2021-2032) Figure 62. Asia OTC Anti-Infective Products Revenue Share by Country (2021-2032) Figure 63. Asia OTC Anti-Infective Products Sales Share by Country (2021-2032) Figure 64. SAMEA OTC Anti-Infective Products Revenue Share by Type (2021-2032) Figure 65. SAMEA OTC Anti-Infective Products Sales Share by Type (2021-2032) Figure 66. SAMEA OTC Anti-Infective Products Revenue Share by Application (2021-2032) Figure 67. SAMEA OTC Anti-Infective Products Sales Share by Application (2021-2032) Figure 68. SAMEA OTC Anti-Infective Products Revenue Share by Country (2021-2032) Figure 69. SAMEA OTC Anti-Infective Products Sales Share by Country (2021-2032) Figure 70. OTC Anti-Infective Products Value Chain Figure 71. Manufacturing Cost Structure Figure 72. OTC Anti-Infective Products Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Antiviral
  • Antibacterial
  • Antifungal
  • Antiseptics
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Teva
  • Johnson & Johnson
  • NOVARTIS
  • MYLAN
  • Roche
  • Lingrui
  • Pfizer
  • CR SANJIU
  • GSK
  • Bayer
  • Sun Pharma
  • Gilead Sciences
  • Cipla
  • Bausch Health
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 OTC Anti-Infective Products Market by Type
  3. 1.2.1 Global OTC Anti-Infective Products Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Antiviral
  5. 1.2.3 Antibacterial
  6. 1.2.4 Antifungal
  7. 1.2.5 Antiseptics
  8. 1.2.6 Others
  9. 1.3 OTC Anti-Infective Products Market by Application
  10. 1.3.1 Global OTC Anti-Infective Products Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Retail Pharmacies
  12. 1.3.3 Online Pharmacies
  13. 1.3.4 Hospital Pharmacies
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 OTC Anti-Infective Products Market Dynamics
  1. 2.1 OTC Anti-Infective Products Industry Trends
  2. 2.2 OTC Anti-Infective Products Industry Drivers
  3. 2.3 OTC Anti-Infective Products Industry Opportunities and Challenges
  4. 2.4 OTC Anti-Infective Products Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global OTC Anti-Infective Products Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global OTC Anti-Infective Products Revenue by Region
  3. 3.2.1 Global OTC Anti-Infective Products Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global OTC Anti-Infective Products Revenue by Region (2021-2026)
  5. 3.2.3 Global OTC Anti-Infective Products Revenue by Region (2027-2032)
  6. 3.2.4 Global OTC Anti-Infective Products Revenue Market Share by Region (2021-2032)
  7. 3.3 Global OTC Anti-Infective Products Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global OTC Anti-Infective Products Sales by Region
  9. 3.4.1 Global OTC Anti-Infective Products Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global OTC Anti-Infective Products Sales by Region (2021-2026)
  11. 3.4.3 Global OTC Anti-Infective Products Sales by Region (2027-2032)
  12. 3.4.4 Global OTC Anti-Infective Products Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global OTC Anti-Infective Products Revenue by Manufacturers
  2. 4.1.1 Global OTC Anti-Infective Products Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global OTC Anti-Infective Products Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global OTC Anti-Infective Products Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global OTC Anti-Infective Products Sales by Manufacturers
  6. 4.2.1 Global OTC Anti-Infective Products Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global OTC Anti-Infective Products Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global OTC Anti-Infective Products Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global OTC Anti-Infective Products Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global OTC Anti-Infective Products Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global OTC Anti-Infective Products Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global OTC Anti-Infective Products Manufacturers, Product Type & Application
  13. 4.7 Global OTC Anti-Infective Products Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global OTC Anti-Infective Products Market CR5 and HHI
  16. 4.8.2 2025 OTC Anti-Infective Products Tier 1, Tier 2, and Tier 3
5 OTC Anti-Infective Products Market by Type
  1. 5.1 Global OTC Anti-Infective Products Revenue by Type
  2. 5.1.1 Global OTC Anti-Infective Products Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global OTC Anti-Infective Products Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global OTC Anti-Infective Products Revenue Market Share by Type (2021-2032)
  5. 5.2 Global OTC Anti-Infective Products Sales by Type
  6. 5.2.1 Global OTC Anti-Infective Products Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global OTC Anti-Infective Products Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global OTC Anti-Infective Products Sales Market Share by Type (2021-2032)
  9. 5.3 Global OTC Anti-Infective Products Price by Type
6 OTC Anti-Infective Products Market by Application
  1. 6.1 Global OTC Anti-Infective Products Revenue by Application
  2. 6.1.1 Global OTC Anti-Infective Products Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global OTC Anti-Infective Products Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global OTC Anti-Infective Products Revenue Market Share by Application (2021-2032)
  5. 6.2 Global OTC Anti-Infective Products Sales by Application
  6. 6.2.1 Global OTC Anti-Infective Products Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global OTC Anti-Infective Products Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global OTC Anti-Infective Products Sales Market Share by Application (2021-2032)
  9. 6.3 Global OTC Anti-Infective Products Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva OTC Anti-Infective Products Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson OTC Anti-Infective Products Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 NOVARTIS
  14. 7.3.1 NOVARTIS Company Information
  15. 7.3.2 NOVARTIS Business Overview
  16. 7.3.3 NOVARTIS OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 NOVARTIS OTC Anti-Infective Products Product Portfolio
  18. 7.3.5 NOVARTIS Recent Developments
  19. 7.4 MYLAN
  20. 7.4.1 MYLAN Company Information
  21. 7.4.2 MYLAN Business Overview
  22. 7.4.3 MYLAN OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 MYLAN OTC Anti-Infective Products Product Portfolio
  24. 7.4.5 MYLAN Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Roche OTC Anti-Infective Products Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 Lingrui
  32. 7.6.1 Lingrui Company Information
  33. 7.6.2 Lingrui Business Overview
  34. 7.6.3 Lingrui OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lingrui OTC Anti-Infective Products Product Portfolio
  36. 7.6.5 Lingrui Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer OTC Anti-Infective Products Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 CR SANJIU
  44. 7.8.1 CR SANJIU Company Information
  45. 7.8.2 CR SANJIU Business Overview
  46. 7.8.3 CR SANJIU OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 CR SANJIU OTC Anti-Infective Products Product Portfolio
  48. 7.8.5 CR SANJIU Recent Developments
  49. 7.9 GSK
  50. 7.9.1 GSK Company Information
  51. 7.9.2 GSK Business Overview
  52. 7.9.3 GSK OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 GSK OTC Anti-Infective Products Product Portfolio
  54. 7.9.5 GSK Recent Developments
  55. 7.10 Bayer
  56. 7.10.1 Bayer Company Information
  57. 7.10.2 Bayer Business Overview
  58. 7.10.3 Bayer OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Bayer OTC Anti-Infective Products Product Portfolio
  60. 7.10.5 Bayer Recent Developments
  61. 7.11 Sun Pharma
  62. 7.11.1 Sun Pharma Company Information
  63. 7.11.2 Sun Pharma Business Overview
  64. 7.11.3 Sun Pharma OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sun Pharma OTC Anti-Infective Products Product Portfolio
  66. 7.11.5 Sun Pharma Recent Developments
  67. 7.12 Gilead Sciences
  68. 7.12.1 Gilead Sciences Company Information
  69. 7.12.2 Gilead Sciences Business Overview
  70. 7.12.3 Gilead Sciences OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Gilead Sciences OTC Anti-Infective Products Product Portfolio
  72. 7.12.5 Gilead Sciences Recent Developments
  73. 7.13 Cipla
  74. 7.13.1 Cipla Company Information
  75. 7.13.2 Cipla Business Overview
  76. 7.13.3 Cipla OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Cipla OTC Anti-Infective Products Product Portfolio
  78. 7.13.5 Cipla Recent Developments
  79. 7.14 Bausch Health
  80. 7.14.1 Bausch Health Company Information
  81. 7.14.2 Bausch Health Business Overview
  82. 7.14.3 Bausch Health OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bausch Health OTC Anti-Infective Products Product Portfolio
  84. 7.14.5 Bausch Health Recent Developments
  85. 7.15 Astellas Pharma
  86. 7.15.1 Astellas Pharma Company Information
  87. 7.15.2 Astellas Pharma Business Overview
  88. 7.15.3 Astellas Pharma OTC Anti-Infective Products Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Astellas Pharma OTC Anti-Infective Products Product Portfolio
  90. 7.15.5 Astellas Pharma Recent Developments
8 North America
  1. 8.1 North America OTC Anti-Infective Products Market Size by Type
  2. 8.1.1 North America OTC Anti-Infective Products Revenue by Type (2021-2032)
  3. 8.1.2 North America OTC Anti-Infective Products Sales by Type (2021-2032)
  4. 8.1.3 North America OTC Anti-Infective Products Price by Type (2021-2032)
  5. 8.2 North America OTC Anti-Infective Products Market Size by Application
  6. 8.2.1 North America OTC Anti-Infective Products Revenue by Application (2021-2032)
  7. 8.2.2 North America OTC Anti-Infective Products Sales by Application (2021-2032)
  8. 8.2.3 North America OTC Anti-Infective Products Price by Application (2021-2032)
  9. 8.3 North America OTC Anti-Infective Products Market Size by Country
  10. 8.3.1 North America OTC Anti-Infective Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America OTC Anti-Infective Products Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America OTC Anti-Infective Products Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe OTC Anti-Infective Products Market Size by Type
  2. 9.1.1 Europe OTC Anti-Infective Products Revenue by Type (2021-2032)
  3. 9.1.2 Europe OTC Anti-Infective Products Sales by Type (2021-2032)
  4. 9.1.3 Europe OTC Anti-Infective Products Price by Type (2021-2032)
  5. 9.2 Europe OTC Anti-Infective Products Market Size by Application
  6. 9.2.1 Europe OTC Anti-Infective Products Revenue by Application (2021-2032)
  7. 9.2.2 Europe OTC Anti-Infective Products Sales by Application (2021-2032)
  8. 9.2.3 Europe OTC Anti-Infective Products Price by Application (2021-2032)
  9. 9.3 Europe OTC Anti-Infective Products Market Size by Country
  10. 9.3.1 Europe OTC Anti-Infective Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe OTC Anti-Infective Products Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe OTC Anti-Infective Products Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China OTC Anti-Infective Products Market Size by Type
  2. 10.1.1 China OTC Anti-Infective Products Revenue by Type (2021-2032)
  3. 10.1.2 China OTC Anti-Infective Products Sales by Type (2021-2032)
  4. 10.1.3 China OTC Anti-Infective Products Price by Type (2021-2032)
  5. 10.2 China OTC Anti-Infective Products Market Size by Application
  6. 10.2.1 China OTC Anti-Infective Products Revenue by Application (2021-2032)
  7. 10.2.2 China OTC Anti-Infective Products Sales by Application (2021-2032)
  8. 10.2.3 China OTC Anti-Infective Products Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia OTC Anti-Infective Products Market Size by Type
  2. 11.1.1 Asia OTC Anti-Infective Products Revenue by Type (2021-2032)
  3. 11.1.2 Asia OTC Anti-Infective Products Sales by Type (2021-2032)
  4. 11.1.3 Asia OTC Anti-Infective Products Price by Type (2021-2032)
  5. 11.2 Asia OTC Anti-Infective Products Market Size by Application
  6. 11.2.1 Asia OTC Anti-Infective Products Revenue by Application (2021-2032)
  7. 11.2.2 Asia OTC Anti-Infective Products Sales by Application (2021-2032)
  8. 11.2.3 Asia OTC Anti-Infective Products Price by Application (2021-2032)
  9. 11.3 Asia OTC Anti-Infective Products Market Size by Country
  10. 11.3.1 Asia OTC Anti-Infective Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia OTC Anti-Infective Products Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia OTC Anti-Infective Products Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA OTC Anti-Infective Products Market Size by Type
  2. 12.1.1 SAMEA OTC Anti-Infective Products Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA OTC Anti-Infective Products Sales by Type (2021-2032)
  4. 12.1.3 SAMEA OTC Anti-Infective Products Price by Type (2021-2032)
  5. 12.2 SAMEA OTC Anti-Infective Products Market Size by Application
  6. 12.2.1 SAMEA OTC Anti-Infective Products Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA OTC Anti-Infective Products Sales by Application (2021-2032)
  8. 12.2.3 SAMEA OTC Anti-Infective Products Price by Application (2021-2032)
  9. 12.3 SAMEA OTC Anti-Infective Products Market Size by Country
  10. 12.3.1 SAMEA OTC Anti-Infective Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA OTC Anti-Infective Products Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA OTC Anti-Infective Products Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 OTC Anti-Infective Products Value Chain Analysis
  2. 13.1.1 OTC Anti-Infective Products Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 OTC Anti-Infective Products Production Mode & Process
  6. 13.2 OTC Anti-Infective Products Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 OTC Anti-Infective Products Distributors
  9. 13.2.3 OTC Anti-Infective Products Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst